131 related articles for article (PubMed ID: 19195024)
1. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma.
Onda T; Uzawa K; Endo Y; Bukawa H; Yokoe H; Shibahara T; Tanzawa H
Br J Cancer; 2006 Mar; 94(5):698-709. PubMed ID: 16479256
[TBL] [Abstract][Full Text] [Related]
3. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
6. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
[TBL] [Abstract][Full Text] [Related]
7. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020
[TBL] [Abstract][Full Text] [Related]
8. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
Dong SW; Zhang P; Zhong RR; Liu Q
Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
10. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
[TBL] [Abstract][Full Text] [Related]
11. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
12. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Nakamura E; Kozaki K; Tsuda H; Suzuki E; Pimkhaokham A; Yamamoto G; Irie T; Tachikawa T; Amagasa T; Inazawa J; Imoto I
Cancer Sci; 2008 Jul; 99(7):1390-400. PubMed ID: 18452558
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
15. [Expression of full-length spleen tyrosine kinase in the oral squamous cell carcinoma and its relationship with tumor invasion and metastasis].
Wang Z; Chen J; Chu W; Da M; Ma L; Wu M; Zhong Y; Wang Z; Song X; Wu Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):519-23. PubMed ID: 26688948
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
17. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
[TBL] [Abstract][Full Text] [Related]
20. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
